The upregulation of activated caspase-3 and low DAPI signals in normoglycemic ARPE-19 cells with CoPP treatment further demonstrated that the treatment induces cell death under normoglycemia but not hyperglycemia. This evidence concerns the gene CASP3 and Hyperglycemia.